Around 70%and20%0% answered correctly >80% of questions on breast and colorectal cancer tests, respectively.
While evidence on the association between oral contraceptive (OC) use and breast cancer generally suggests little or no increased risk, the question of whether breast cancer risk varies by OC formulation remains controversial.
We identified 34 published studies that have reported data that can be used to address the question of whether breast cancer is a Lynch syndrome cancer.
See related research by Lotsari et al., http://breast-cancer-research.com/content/14/3/R90 In a comprehensive analysis of all available breast cancers from among 200 Lynch syndrome (LS) families in a nationwide registry in Finland, Lotsari and colleagues [ 1] address the question of whether breast cancer is an integral part of LS.
By using "cleavage for a purpose", she writes, is "a trickier call, because it raises the question of when a breast is just a breast, and when it becomes something else entirely".
However, some researchers question the protection of breast milk against childhood obesity [ 19].
If doing so, the question of risk for breast cancer in BRCA1/2 carrying kindreds in women not having the family's BRCA mutation will become an issue to clarify [ 13], as will the biology of such breast cancers.
79 In this context, PRIME 2 (Post-operative Radiotherapy In Minimum-risk Elderly – Phase II), an international, randomized, controlled Phase III trial, set out to address the question of whether whole breast radiation therapy (WBRT) could be omitted in carefully defined groups of older patients.
An additional question about the causes of breast cancer disparities approached significance (p =.06), while a question about the role of culture in health showed no change between pre- and post-test.
Although the association of the luminal phenotype with Tamoxifen and ESR1 expression level provides an additional validation of the specificity of the methodology, a more pressing question in the context of breast cancer therapy is the basal phenotype since effective treatments for this group of patients are limited.
